当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Mavyret
通用名称
glecaprevir/pibrentasvir
儿科标签批准日期
2019/9/26 0:00:00
特定指示/秒
Chronic hepatitis C virus infection (HCV) 12 years and older or weighing at least 45 kg
标签更改摘要
- The treatment duration for chronic HCV for treatment-naïve patients was changed from 12 weeks to 8 weeks.
- The new 8-week treatment duration for genotypes (GTs) 1,2,3,4,5 and 6 for treatment-naïve patients with compensated cirrhosis with Chronic Hepatitis C Virus (HCV) infection is supported by the EXPEDITION-8 study.
- Information on dosing, and clinical trial.
- New dosing regimen.
- Postmarketing study.